Danaher Corporation (DHR) Shares Sold by Hartford Investment Management Co.

Hartford Investment Management Co. lowered its position in Danaher Corporation (NYSE:DHR) by 4.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 138,737 shares of the conglomerate’s stock after selling 7,045 shares during the period. Hartford Investment Management Co.’s holdings in Danaher Corporation were worth $11,708,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Peddock Capital Advisors LLC boosted its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after buying an additional 598 shares in the last quarter. ClariVest Asset Management LLC bought a new stake in shares of Danaher Corporation during the first quarter worth approximately $157,000. Motco boosted its stake in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares in the last quarter. Finally, Baystate Wealth Management LLC boosted its stake in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Danaher Corporation (NYSE DHR) traded down 0.05% during trading on Friday, hitting $80.87. The stock had a trading volume of 2,861,306 shares. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The stock has a market cap of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. The firm has a 50 day moving average of $82.32 and a 200-day moving average of $84.22.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the firm posted $0.90 earnings per share. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post $3.95 earnings per share for the current year.

WARNING: This story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://sportsperspectives.com/2017/08/20/danaher-corporation-dhr-shares-sold-by-hartford-investment-management-co.html.

A number of analysts have recently commented on the company. Wells Fargo & Company assumed coverage on Danaher Corporation in a research report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub cut Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Finally, BTIG Research reissued a “buy” rating and issued a $92.00 price target on shares of Danaher Corporation in a research report on Sunday, April 23rd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $91.76.

In other news, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at $1,513,787.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the sale, the senior vice president now owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock valued at $3,206,426 over the last quarter. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply